Magreni Angelina, Bann Darrin V, Schubart Jane R, Goldenberg David
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey.
Division of Outcomes Research and Quality, Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey.
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):319-23. doi: 10.1001/jamaoto.2014.3740.
The incidence of thyroid cancer has increased over the past 30 years. Thyroid cancer is less common in blacks than in persons of white descent, and it has been most common in Asians/Pacific Islanders until recently.
To determine whether the incidence of thyroid cancer is increasing at disproportionate rates for different races and ethnicities.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective review. Study participants were individuals with thyroid cancer in the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 13 database from 1992 through 2010. The SEER 13 registry consists of records from Atlanta (Georgia), Connecticut, Detroit (Michigan), Hawaii, Iowa, New Mexico, San Francisco-Oakland (California), Seattle-Puget Sound (Washington), Utah, Los Angeles (California), San Jose-Monterey (California), rural Georgia, and the Alaska Native Tumor Registry.
The SEER*Stat Joinpoint Regression Program was used to determine the average annual percentage change in thyroid cancer incidence for different races and ethnicities from 1992 through 2010. Trends in thyroid cancer incidence were compared between groups using comparability testing.
During the study period, the average annual percentage change for thyroid cancer was 5.3% (95% CI, 4.8%-5.7%) per year. Stratification of the study population by race revealed that whites experienced the largest increase in age-adjusted thyroid cancer incidence (5.6% per year), followed by blacks (4.8% per year), American Indian/Alaskan natives (3.2% per year), and Asians/Pacific Islanders (2.3% per year). Joinpoint regression comparability testing showed that the increase in disease incidence was not significantly different between whites and blacks (P = .25). However, the increase in incidence for Asians/Pacific Islanders was significantly lower than that for whites and blacks (P < .05). Stratification of the study population by ethnicity revealed that non-Hispanics experienced a larger increase in incidence (5.5% per year) than Hispanics (3.3% per year).
The incidence of thyroid cancer continues to increase in all races and ethnicities. No significant difference was observed between the increase in incidence for whites and blacks. However, the increase in incidence for non-Hispanics was significantly larger than that for Hispanics. The increase in incidence of thyroid cancer was greater in whites than in Asians/Pacific Islanders, so whites now have a higher incidence of thyroid cancer than persons of Asian/Pacific Islander descent.
在过去30年中,甲状腺癌的发病率有所上升。甲状腺癌在黑人中比在白人后裔中更为少见,直到最近,它在亚洲人/太平洋岛民中最为常见。
确定不同种族和族裔的甲状腺癌发病率是否以不成比例的速度上升。
设计、地点和参与者:回顾性研究。研究参与者是1992年至2010年美国国立癌症研究所监测、流行病学和最终结果(SEER)13数据库中的甲状腺癌患者。SEER 13登记处包括来自佐治亚州亚特兰大、康涅狄格州、密歇根州底特律、夏威夷、爱荷华州、新墨西哥州、加利福尼亚州旧金山 - 奥克兰、华盛顿州西雅图 - 普吉特海湾、犹他州、加利福尼亚州洛杉矶、加利福尼亚州圣何塞 - 蒙特雷、佐治亚州农村以及阿拉斯加原住民肿瘤登记处的记录。
使用SEER*Stat Joinpoint回归程序确定1992年至2010年不同种族和族裔甲状腺癌发病率的年均百分比变化。通过可比性测试比较各组甲状腺癌发病率的趋势。
在研究期间,甲状腺癌的年均百分比变化为每年5.3%(95%CI,4.8% - 5.7%)。按种族对研究人群进行分层显示,白人年龄调整后的甲状腺癌发病率增幅最大(每年5.6%),其次是黑人(每年4.8%)、美国印第安人/阿拉斯加原住民(每年3.2%)和亚洲人/太平洋岛民(每年2.3%)。Joinpoint回归可比性测试表明,白人和黑人之间疾病发病率的增加没有显著差异(P = 0.25)。然而,亚洲人/太平洋岛民的发病率增幅明显低于白人和黑人(P < 0.05)。按族裔对研究人群进行分层显示,非西班牙裔的发病率增幅(每年5.5%)高于西班牙裔(每年3.3%)。
所有种族和族裔的甲状腺癌发病率持续上升。白人和黑人发病率的增加未观察到显著差异。然而,非西班牙裔的发病率增幅明显大于西班牙裔。白人甲状腺癌发病率的增幅大于亚洲人/太平洋岛民,因此现在白人的甲状腺癌发病率高于亚洲/太平洋岛民后裔。